Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Change in Acquisitions & Divestments (2016)

Historic Change in Acquisitions & Divestments for Cytosorbents (CTSO) over the last 6 years, with Q3 2016 value amounting to $249000.0.

  • Cytosorbents' Change in Acquisitions & Divestments fell 8333.33% to $249000.0 in Q3 2016 from the same period last year, while for Dec 2017 it was $2.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.2 million for FY2016, which is 5963.57% down from last year.
  • Latest data reveals that Cytosorbents reported Change in Acquisitions & Divestments of $249000.0 as of Q3 2016, which was down 8333.33% from $1.9 million recorded in Q2 2016.
  • In the past 5 years, Cytosorbents' Change in Acquisitions & Divestments ranged from a high of $1.9 million in Q2 2016 and a low of $249000.0 during Q3 2016
  • Over the past 5 years, Cytosorbents' median Change in Acquisitions & Divestments value was $393607.0 (recorded in 2012), while the average stood at $722413.6.
  • In the last 5 years, Cytosorbents' Change in Acquisitions & Divestments soared by 21669.84% in 2015 and then plummeted by 8333.33% in 2016.
  • Over the past 5 years, Cytosorbents' Change in Acquisitions & Divestments (Quarter) stood at $393607.0 in 2012, then changed by 0.0% to $393607.0 in 2013, then changed by 0.0% to $393607.0 in 2014, then skyrocketed by 279.57% to $1.5 million in 2015, then plummeted by 83.33% to $249000.0 in 2016.
  • Its last three reported values are $249000.0 in Q3 2016, $1.9 million for Q2 2016, and $1.5 million during Q4 2015.